- $13.83bn
- $15.81bn
- $4.10bn
- 86
- 35
- 95
- 83
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,957 | 3,018 | 3,765 | 4,122 | 4,105 |
Cost of Revenue | |||||
Gross Profit | 1,052 | 1,058 | 1,319 | 1,365 | 1,519 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 2,523 | 2,557 | 3,127 | 3,526 | 3,365 |
Operating Profit | 435 | 461 | 638 | 596 | 739 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 408 | 432 | 627 | 551 | 619 |
Provision for Income Taxes | |||||
Net Income After Taxes | 362 | 357 | 556 | 483 | 623 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 356 | 359 | 553 | 481 | 623 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 356 | 359 | 553 | 481 | 623 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.36 | 2.26 | 3.44 | 3.36 | 3.97 |
Dividends per Share |